GH vs. HIMS
GH (Guardant Health, Inc.) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — GH in Diagnostics & Research, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 5 years, GH returned 8.09%/yr vs 28.55%/yr for HIMS. Their 0.35 correlation means their historical movements had little consistent relationship.
Performance
GH vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GH achieves a 58.60% return, which is significantly higher than HIMS's -14.47% return.
GH
- 1D
- 6.33%
- 1M
- -3.57%
- 6M
- 42.05%
- YTD
- 58.60%
- 1Y
- 291.09%
- 3Y*
- 62.15%
- 5Y*
- 8.09%
- 10Y*
- —
- ALL TIME*
- 25.30%
HIMS
- 1D
- 2.70%
- 1M
- -24.54%
- 6M
- 2.51%
- YTD
- -14.47%
- 1Y
- -55.60%
- 3Y*
- 46.90%
- 5Y*
- 28.55%
- 10Y*
- —
- ALL TIME*
- 16.38%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $318.22M | $357.11M | $367.60M | |
| $513.38M | $470.49M | $554.38M |
GH vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
GH Guardant Health, Inc. | 58.60% | 234.34% | 12.94% | -0.55% | -72.81% | -22.39% | 64.93% | 1.41% |
HIMS Hims & Hers Health, Inc. | -14.47% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between GH and HIMS is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.33 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.39 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.35 |
The correlation between GH and HIMS shifts across timeframes, from 0.23 (1 year) to 0.39 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
GH:
$21.48B
HIMS:
$6.19B
GH:
-$3.51
HIMS:
-$0.05
GH:
17.71
HIMS:
2.83
GH:
$1.18B
HIMS:
$2.37B
GH:
$769.16M
HIMS:
$1.70B
GH:
-$431.26M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GH vs. HIMS — Risk / Return Rank
GH
HIMS
GH vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Guardant Health, Inc. (GH) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GH | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +5.57 | ||
| Sortino ratioReturn per unit of downside risk | +5.79 | ||
| Omega ratioGain probability vs. loss probability | 1.63 | 0.91 | +0.72 |
| Calmar ratioReturn relative to maximum drawdown | 9.02 | -0.75 | +9.77 |
| Martin ratioReturn relative to average drawdown | 22.69 | -1.19 | +23.88 |
Loading charts...
Drawdowns
GH vs. HIMS - Drawdown Comparison
The maximum GH drawdown since its inception was -91.03%, roughly equal to the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for GH and HIMS.
Loading charts...
Drawdown Indicators
| GH | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.03% | -87.29% | -3.74% |
Max Drawdown (1Y)Largest decline over 1 year | -32.98% | -77.08% | +44.10% |
Max Drawdown (3Y)Largest decline over 3 years | -59.79% | -78.88% | +19.09% |
Max Drawdown (5Y)Largest decline over 5 years | -87.84% | -78.88% | -8.96% |
Current DrawdownCurrent decline from peak | -9.55% | -59.60% | +50.05% |
Average DrawdownAverage peak-to-trough decline | -50.97% | -43.40% | -7.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.08% | 50.87% | -37.79% |
Volatility
GH vs. HIMS - Volatility Comparison
The current volatility for Guardant Health, Inc. (GH) is 14.67%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 29.05%. This indicates that GH experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GH | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.67% | 29.05% | -14.38% |
Volatility (6M)Calculated over the trailing 6-month period | 41.58% | 74.17% | -32.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.10% | 91.82% | -30.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.10% | 84.07% | -15.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.19% | 77.60% | -9.41% |
Dividends
GH vs. HIMS - Dividend Comparison
Neither GH nor HIMS has paid dividends to shareholders.
Financials
GH vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Guardant Health, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GH vs. HIMS - Profitability Comparison
GH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Guardant Health, Inc. reported a gross profit of 219.03M and revenue of 334.98M. Therefore, the gross margin over that period was 65.4%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
GH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Guardant Health, Inc. reported an operating income of -129.12M and revenue of 334.98M, resulting in an operating margin of -38.6%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
GH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Guardant Health, Inc. reported a net income of -120.14M and revenue of 334.98M, resulting in a net margin of -35.9%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
GH and HIMS have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (29.05%) compared to GH (14.67%). In terms of maximum drawdown, GH dropped -91.03% vs HIMS's -87.29%.
GH currently has the higher Sharpe Ratio (4.93 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GH and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer